These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9831312)

  • 21. Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age.
    Palomba S; Falbo A; Orio F; Russo T; Sbano F; D'Alessandro P; Cariati F; Tolino A; Colao A; Zullo F
    Gynecol Endocrinol; 2006 Jun; 22(6):329-35. PubMed ID: 16785158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Purified FSH in small doses. Is this not the best current treatment of polycystic ovaries resistant to clomid? 73 cycles].
    Drapier-Faure E
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(5):651-5. PubMed ID: 1955660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovulation induction: a mini review.
    Messinis IE
    Hum Reprod; 2005 Oct; 20(10):2688-97. PubMed ID: 16006478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Induction of follicle maturation with "pure" FSH in polycystic ovary syndrome].
    Birkhäuser MH; Huber PR; Neuenschwander E; Näpflin S
    Geburtshilfe Frauenheilkd; 1988 Apr; 48(4):220-7. PubMed ID: 3132413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B; Yumusak OH; Tokmak A
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive factors of success in ovulation induction with recombinant FSH: results of Indigo study].
    Cédrin-Durnerin I; Belaisch-Allart J; Avril C; Pouly JL
    Gynecol Obstet Fertil; 2010 Feb; 38(2):105-13. PubMed ID: 20106707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome.
    Ozgun MT; Uludag S; Oner G; Batukan C; Aygen EM; Sahin Y
    J Obstet Gynaecol; 2011; 31(3):245-9. PubMed ID: 21417650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
    Papaleo E; Doldi N; De Santis L; Marelli G; Marsiglio E; Rofena S; Ferrari A
    Hum Reprod; 2001 Nov; 16(11):2263-6. PubMed ID: 11679501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
    Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
    Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M; Sjöblom P; Pousette A; Hillensjö T
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone.
    Yong EL; Ng SC; Chan C; Kumar J; Teo LS; Ratnam S
    Int J Gynaecol Obstet; 1997 Jun; 57(3):305-11. PubMed ID: 9215494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.